Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults
Completed · Phase 3
Conditions studied: HIV-1 Infection
In brief
The primary objective of this study is to evaluate the efficacy of switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) relative to continuing on a baseline regimen consisting of abacavir/lamivudine (ABC/3TC) plus a 3rd antiretroviral agent in HIV-1 infected participants.
Key facts
- Study ID
- NCT02605954
- Run by
- Gilead Sciences
- People needed
- 275
- Starts
- 2015-11-18
- Expected to finish
- 2018-01-24
- Last updated by the study team
- 2018-11-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Spectrum Medical Group — Phoenix, Arizona, United States
- Ruane Clinical Research Group — Los Angeles, California, United States
- Capital Medical Associates, P.C. — Washington D.C., District of Columbia, United States
- Georgetown University — Washington D.C., District of Columbia, United States
- Gary Richmond, MD, PA, Inc. — Fort Lauderdale, Florida, United States
- Midway Immunology & Research Center, LLC — Ft. Pierce, Florida, United States
- Steinhart Medical Associates dba The Kinder Medical Group — Miami, Florida, United States
- Triple O Research Institute PA — West Palm Beach, Florida, United States
- The Positive Health Clinic, Allegheny Health Network — Pittsburgh, Pennsylvania, United States
- Central Texas Clinical Research — Austin, Texas, United States
- AIDS Arms, Inc./Trinity Health & Wellness Center — Dallas, Texas, United States
- Tarrant County ID Associates — Fort Worth, Texas, United States
- CHU - Groupe Saint-Andre — Bordeaux, France
- Hopital Henri Mondor — Créteil, France
- Hopital Europeen Marseille — Marseille, France
- C.H.U. de Nantes — Nantes, France
- C.H.U. de NICE — Nice, France
- CHU Hotel Dieu — Paris, France
- Hopital Lariboisiere — Paris, France
- Hopital Necker les Enfants Malades — Paris, France
- Hopital Saint Antoine — Paris, France
- Hopital Saint Louis — Paris, France
- Centre Hospitalier Gustave Dron — Tourcoing, France
- Epimed GmbH — Berlin, Germany
- Universitatsklinikum Essen — Essen, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.